Skip to main content

Main menu

  • About Us
    • Leadership
    • Our Team
    • Vision, Mission and Values
    • Health and Economic Impact
    • Strategic Plan
  • Our Research
    • Research Focus
      • Brain Health
      • Cancer
      • Cardiovascular Conditions and Diseases
      • Digital Health
      • Health Policy
      • Immunity and Infectious Diseases
      • Joint Health and Mobility
      • Respiratory and Lung Health
      • Spinal Cord Injury and Rehabilitation
    • Research Centres and Programs
      • BC Centre on Substance Use
      • Centre for Aging SMART
      • Centre for Cardiovascular Innovation
      • Centre for Clinical Epidemiology and Evaluation
      • Centre for Lung Health
      • Djavad Mowafaghian Centre for Brain Health
      • Immunity and Infection Research Centre
      • International Collaboration On Repair Discoveries
      • Ovarian Cancer Research Centre
      • Vancouver Prostate Centre
      • Community Research Program
      • Emergency Medicine Research Program
      • Hematology Research Program
      • Skin Research Program
      • Other Research Focus Areas
    • News and Stories
    • Researcher Directory
    • Events and Workshops
  • Research Services
    • New to VCHRI
      • Working at VCHRI
      • Regulations and Training
      • Membership with VCHRI
    • Starting Your Project
      • Research Facilitation
      • Awards and Funding
      • Grant Management
      • Operational Approval
    • Developing Your Project
      • Clinical Trials Administration
      • Clinical Research Unit
      • CST Cerner at VCH
      • Research Privacy
      • Financial Policies and Procedures
    • Additional Support
      • Education and Training
      • Communications and Branding
      • Media Relations
      • Study Recruitment Support
      • Innovation and Industry Partnership
    • Internal Awards
    • Clinical Research
    • Innovation and Partnership
  • Participate in Research
    • Reasons to Participate
    • Participant Stories
    • Find a Study
    • Recruitment Support

User menu

  • Log in

Breadcrumb

  1. Home
  2. Participate in Research
  3. Blood, Heart and Circulation

Blood, Heart and Circulation

Recruiting

Comparing treatments for newly diagnosed multiple myeloma patients

The purpose of this study is to compare the standard of care therapy (VRd + Rd therapy) and CAR-T therapy (VRd + CAR-T) for newly diagnosed multiple myeloma patients who do not plan to receive hematopoietic stem cell transplant as initial therapy.

Status
Recruiting
Principal Investigator
Kevin Song
Body Locations and Systems
Blood, Heart and Circulation
Age
18 and above

Evaluating the safety of an ultrasound-guided vascular closure device

The purpose of this study is to collect real-world data on the safety and efficacy of the MANTA vascular closure device using ultrasound guidance in stopping blood flow/close catheter access sites at the end of large-bore interventional cardiology procedures compared to using pre-procedural depth locator measurements.

Status
Recruiting
Principal Investigator
David Wood
Body Locations and Systems
Blood, Heart and Circulation
Age
21 and above

Evaluating colchicine to prevent vascular events after hemorrhage

The purpose of this study is to determine if the use of colchicine, a drug that reduces inflammation, can lower the risk of having a stroke or heart attack from blood clots compared to placebo, and improve recovery in people with a recent brain bleed.

Status
Recruiting
Principal Investigator
Thalia Field
Body Locations and Systems
Blood, Heart and Circulation
Brain and Nerves
Age
18 and above

Treating post-thrombotic syndrome with micronized purified flavonoid fraction

The purpose of this study is to determine whether a 6-month course of oral micronised purified flavonoid fraction (MPFF), compared with placebo, improves the symptoms and signs of post-thrombotic syndrome (PTS) and quality of life at six months follow-up.

Status
Recruiting
Principal Investigator
Agnes Lee
Body Locations and Systems
Blood, Heart and Circulation
Age
18 and above

Comparing ablation strategies to treat atrial fibrillation

The purpose of this study is to collect information to determine if some ablation strategies work better than others for treating atrial fibrillation.

Status
Recruiting
Principal Investigator
Jason Andrade
Body Locations and Systems
Blood, Heart and Circulation
Age
19 and above

Assessing the impact of a study drug to reduce cardiovascular risk

The purpose of this study is to support an indication of inclisiran for the reduction of cardiovascular risk in participants with established atherosclerotic cardiovascular disease who have elevated low-density lipoprotein cholesterol levels despite being on a background of well-tolerated dose of a high-intensity statin therapy. 

Status
Recruiting
Principal Investigator
G.B. John Mancini
Body Locations and Systems
Blood, Heart and Circulation
Age
40 and above

Optimizing drug treatment for chronic myelogenous leukemia

The purpose of this study is to optimize the treatment of asciminib in patients with chronic myelogenous leukemia in chronic phase (CML-CP), who have previously been treated with at least 2 tyrosine kinase inhibitors. Additionally, this study will investigate the usage of two different dosing regimes of asciminib, 80mg daily and 40mg twice daily.

Status
Recruiting
Principal Investigator
Donna Forrest
Body Locations and Systems
Blood, Heart and Circulation
Age
18 and above

Comparing treatment for atrial fibrillation in the emergency department

The purpose of this study is to compare standard treatment against a newly approved medication for patients presenting to the emergency department with a heart condition called atrial fibrillation. A sub-study will also look at a new consenting process in the emergency department and the experience of patients with this consent process.

Status
Recruiting
Principal Investigator
Corinne Hohl
Body Locations and Systems
Blood, Heart and Circulation
Age
18 and above

Advancing cardiac care-based rapid assessment and treatment of high cholesterol

The purpose of this study is to understand the ability of genetic testing to identify familial hypercholesterolemia among patients with acute cardiac event in hospital settings and to investigate the impact of genetic diagnosis on physician behaviour, medication use and decreasing cholesterol to an acceptable level.

Status
Recruiting
Principal Investigator
Liam Brunham
Body Locations and Systems
Blood, Heart and Circulation
Area
Vancouver
Age
18-60

Automated detection of autonomic dysreflexia via deep learning

The purpose of this study is to investigate if and how retinal blood vessels change after a spinal cord injury (SCI) and the associations of these changes with cardiovascular diseases. Using images of retinal blood vessels, we will develop a deep learning-based screening tool for autonomic dysreflexia, a cardiovascular complication unique to SCI.

Recruitment Poster

Status
Recruiting
Principal Investigator
Ipek Oruc
Body Locations and Systems
Blood, Heart and Circulation
Eyes and Vision

PD Hypotension Study

The purpose of this study is to investigate whether Electrical Vestibular Stimulation (EVS) can lessen orthostatic hypotension in Parkinson’s disease patients. We aim to determine if individual precision-designed EVS stimulus can be optimized for improvements in hypotension.

Status
Recruiting
Principal Investigator
Martin McKeown
Body Locations and Systems
Blood, Heart and Circulation
Brain and Nerves
Area
Vancouver
Age
55-85

Long-Term Follow-up Protocol for Subjects Treated With Gene-Modified T Cells

The purpose of this study it to examine the safety and efficacy of gene-modified T cell therapy in patients who have previously received the treatment. 

Status
Recruiting
Principal Investigator
Kevin Hay
Body Locations and Systems
Blood
Area
Vancouver

CAN-ACCESS

The purpose of the study is to find the best technique and tools for gaining access to left and right heart arteries using x-rays that show blood flow, in patients who are having a specific Medtronic heart valve inserted.

Status
Recruiting
Principal Investigator
Janarthanan Sathananthan
Body Locations and Systems
Heart
Area
Vancouver
Age
18 and above

HORIZON

The purpose of the study is to determine the safety and effectiveness of the drug TQJ230 to lower Lipoprotein(a) to reduce cardiovascular events in patients with a history of heart disease.

Status
Recruiting
Principal Investigator
G.B. John Mancini
Body Locations and Systems
Heart
Area
Vancouver
Age
18 - 80

PULSED AF

The purpose of the study is to provide data demonstrating the safety and effectiveness of the PulseSelect™ PFA System for the treatment of atrial fibrillation.

Status
Recruiting
Principal Investigator
Jason Andrade
Body Locations and Systems
Heart
Atrial Fibrillation
Area
Vancouver
Age
18 to 80

EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)

The purpose of this study is to determine if the drug empagliflozin helps to lower the chances of having to go to the hospital for heart failure and whether it lowers the chances of dying from cardiovascular disease.

Status
Recruiting
Principal Investigator
Christopher Fordyce
Body Locations and Systems
Heart Attack
Area
Vancouver
Age
18 and above

Dapagliflozin and Effect on Cardiovascular Events in Acute Heart Failure -Thrombolysis in Myocardial Infarction 68 (DAPA ACT HF-TIMI 68)

The purpose of the study is to evaluate the effect of in-hospital initiation of dapagliflozin versus placebo on the clinical outcome of cardiovascular death or worsening heart failure.

Status
Recruiting
Principal Investigator
Graham Wong
Body Locations and Systems
Heart Failure
Area
Vancouver
Age
18 and above

APIxaban Cancer Associated Thrombosis (API-CAT)

The purpose of this study is to determine whether a reduced dose of apixaban is non-inferior to and safer than the full dose of apixaban for the prevention of recurrent venous thromboembolism (VTE) in active cancer patients.

Status
Recruiting
Principal Investigator
Agnes Lee
Body Locations and Systems
Blood
Area
Vancouver
Age
18 and above

A Study of CC-97540, CD19-targeted NEX-T Chimeric Antigen Receptor (CAR) T Cells, in Subjects With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

The purpose of this study is to evaluate the safety and efficacy of CC-97540 CAR-T cell treatment for subjects with relapsed or refractory B-cell non-Hodgkin lymphoma.

Status
Recruiting
Principal Investigator
Kevin Hay
Body Locations and Systems
Blood
Area
Vancouver
Age
18 and above

Standardized Invasive Hemodynamics for Elevated Gradients Post TAVR (DISCORDANCE)

The purpose of the study is to compare differences in blood flow and valve pressures by two different methods in patients who are having transcatheter aortic valve replacement.

Status
Recruiting
Principal Investigator
David Wood
Body Locations and Systems
Heart Disease
Area
Vancouver

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Next page
Subscribe to Blood, Heart and Circulation

Get updates!

Join our newsletter mailing list to stay up to date on features and releases.

Subscribe

Quick Links

  • News and Stories
  • Careers
  • Events
  • Media Enquiries

Follow Us

  • Twitter
  • LinkedIn

© 2023 VCHRI. All rights reserved.

  • Contact
  • Privacy Policy